Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis
✍ Scribed by Angelika Reiner; Georg Reiner; Jürgen Spona; Michael Schemper; Johann H. Holzner
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 609 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
A detailed histopathologic analysis of 399 primary breast carcinomas was performed, and several morphologic features were correlated with the estrogen receptor (ER) status. In all cases ER status was determined immunocytochemically by estrogen receptor immunocytochemical assay (ER-ICA). In 359 carcinomas ER status was also biochemically determined. Invasive lobular, mucoid, and tubular carcinomas rather than ductal carcinomas were ER-positive more frequently in ER-ICA. Medullary and papillary carcinomas had corresponding lower or higher ER positivity, respectively, by both methods. The correlation of histologic grade and its single factors with ER status was statistically significant by both methods. Lymphocytic reaction to tumor showed a significant inverse relationship to ER status by both methods. A statistically significant higher number of ER-positive carcinomas in ER-ICA and dextran-coated charcoal assay (DCC) occurred when elastic tissue was present. Different associations were found between stromal content, tumor diameter, and ER status in DCC and ER-ICA, respectively.
Cuncer 61:1149-1154,1988.
N RECENT YEARS several investigators demonstrated I correlations between the presence of the estrogen receptor (ER) and various histopathologic factors of primary breast carcinomas. These reports, however, yielded contradictory results. In several studies correlations between ER status and some histologic tumor types, like medullary, mucoid, or invasive lobular carcinomas, have been dem~nstrated.'-~ In some studies a relationship between histologic tumor grade and ER status was r e p ~r t e d . ~. ~. ~' ' In other investigations into these factors no such relationships could be demonstrated. 1 * 8 ~1 2 ~1 3
The discrepancies may, in part, be the result of different methods of biochemical ER assay. Other reasons for the discrepancies may also be differences in evaluation and terminology, and variations of histopathologic features within a tumor.I3
It is now possible to determine ER status by direct immunocytochemical localization on tissue sections with monoclonal antibodies. 14-17 Therefore, this study was performed to investigate whether correlations be-
📜 SIMILAR VOLUMES
Data from immunocytochemical assessment of estrogen receptor (ER) regulation in MCF-7 cells under estrogenic and anti-estrogenic stimulation were compared with those obtained by enzyme immunoassay (Abbott ER-EIA). Similar trends were observed, although ER level variations were less marked when asses
Evaluation of estrogen (ER) and progesterone (PR) receptor content is now an important procedure in the management of breast cancer patients. Production of monoclonal antibodies to ER and PR has permitted development of an enzyme immunoassay (EIA) and immunocytochemical assay (ICA). This study compa
Human breast carcinomas (n = 232) were evaluated for estrogen and progesterone receptors (ER, PR) by immunohistochemical study and by cytosol steroid-binding assay (n = 185). The staining was scored (histoscore) by estimates of relative nuclear staining intensity and the percentage of positively sta